NDC 51655-535

Metoprolol Tartate

Metoprolol Tartate

Metoprolol Tartate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is Metoprolol Tartrate.

Product ID51655-535_fb98ff8e-3de0-4300-b6c7-5401d5856239
NDC51655-535
Product TypeHuman Prescription Drug
Proprietary NameMetoprolol Tartate
Generic NameMetoprolol Tartate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-06-02
Marketing CategoryANDA / ANDA
Application NumberANDA074644
Labeler NameNorthwind Pharmaceuticals
Substance NameMETOPROLOL TARTRATE
Active Ingredient Strength50 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-535-25

60 TABLET in 1 BOTTLE, DISPENSING (51655-535-25)
Marketing Start Date2014-06-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-535-52 [51655053552]

Metoprolol Tartate TABLET
Marketing CategoryANDA
Application NumberANDA074644
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-06-02
Inactivation Date2020-01-31

NDC 51655-535-26 [51655053526]

Metoprolol Tartate TABLET
Marketing CategoryANDA
Application NumberANDA074644
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-04-01
Inactivation Date2020-01-31

NDC 51655-535-25 [51655053525]

Metoprolol Tartate TABLET
Marketing CategoryANDA
Application NumberANDA074644
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-09
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL TARTRATE50 mg/1

OpenFDA Data

SPL SET ID:760c63bd-1c1c-4a89-9f02-48aadb750484
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866514

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.